Levels of migraine-related disability, physical functioning, and tenderness, but not catastrophizing, may allow to distinguish between chronic and episodic migraine in children and adolescents.
Geographic location and ethnicity may affect the nature of factors that act as triggers of migraine and tension-type headache.
A single-item global rating scale of migraine severity may be a rapid and efficient way for clinicians to obtain information about disease severity, but requires validation in future prospective studies.
The 7-item Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome Role Function-Restrictive domain was found to represent a reliable and valid tool for assessing the functional impact in participants of clinical trials of episodic and chronic migraine.
The demographic characteristics and migraine diagnosis of pediatric patients with headache were found to be associated with the use of evidence-based medicine and prescriptions for opioids and barbiturates as first-line treatment.
Deep brain stimulation for chronic cluster headaches leads to a significant reduction of headache load of up to 140 months of follow-up.
International Classification of Headache Disorders 3rd edition criteria may not be useful in diagnosing children 6 years of age or younger.
Individuals with migraine who are obese may have reduced migraine frequency, lower pain intensity, shorter attack duration, and improved disability after losing weight.
The Headache-specific Locus of Control scale may represent a reliable and valid tool to assess headache-specific locus of control in individuals with migraine.
The phenomenon of cutaneous allodynia is thought to be associated with greater chance for disease progression and lower efficacy of acute therapies.